BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11593153)

  • 41. [Role of chemo(radio)theray prior to surgery for stage IIIa non-small cell lung carcinoma (localized non-resectable tumor)].
    Smit EF; van Mourik JC; Slotman BJ; Postmus PE
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):1992-6. PubMed ID: 10535055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The results of combined treatment for stage III lung cancer including the use of intraoperative radiotherapy].
    Dobrodeev AIu; Zav'ialov AA; Tyzikov SA; Musabaeva LI
    Vopr Onkol; 2013; 59(5):606-10. PubMed ID: 24260889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Assessment of induction therapy and resection in stage IIIb non-small cell lung cancer].
    Togashi K; Sugawara M; Miyamura H; Sato Y; Kourakata H; Nishibori T; Saito H; Sato K
    Kyobu Geka; 1999 Nov; 52(12):1016-9. PubMed ID: 10554488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour.
    Marra A; Eberhardt W; Pöttgen C; Theegarten D; Korfee S; Gauler T; Stuschke M; Stamatis G
    Eur Respir J; 2007 Jan; 29(1):117-26. PubMed ID: 16971407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability.
    Hampel M; Dally I; Walles T; Steger V; Veit S; Kyriss T; Friedel G
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):461-6. PubMed ID: 19775901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP
    Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlates of benefit from neoadjuvant chemotherapy before radiotherapy in non-small cell lung cancer: a meta-analytical approach with meta-regression analysis.
    Bozcuk H; Artac M; Ozdogan M
    J BUON; 2010; 15(1):43-50. PubMed ID: 20414926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy.
    Alexander BM; Othus M; Caglar HB; Allen AM
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1381-7. PubMed ID: 20605346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lung resection in a neoadjuvant protocol.
    Klein J; Král V; Neoral C; Bohanes T; Aujeský R; Kolek V; Grygárková I; Hajdúch M; Tichý T
    Med Sci Monit; 2000; 6(5):937-40. PubMed ID: 11208434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer.
    Koshy M; Goloubeva O; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1388-94. PubMed ID: 20605359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.
    De Leyn P; Vansteenkiste J; Lievens Y; Van Raemdonck D; Nafteux P; Decker G; Coosemans W; Decaluwé H; Moons J; Lerut T
    J Thorac Oncol; 2009 Jan; 4(1):62-8. PubMed ID: 19096308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):195-6. PubMed ID: 11355584
    [No Abstract]   [Full Text] [Related]  

  • 53. Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis.
    Refai M; Brunelli A; Rocco G; Ferguson MK; Fortiparri SN; Salati M; La Rocca A; Kawamukai K
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):535-9. PubMed ID: 19836257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
    Torre W; Sierra A
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: a single-center analysis of 161 cases.
    Semrau S; Klautke G; Fietkau R
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):96-104. PubMed ID: 20350789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of G-CSF-producing invasive apical cancer resected following preoperative adjuvant therapy.
    Takagi Y; Nakamura H; Miwa K; Adachi Y; Fujioka S; Haruki T; Taniguchi Y
    Thorac Cardiovasc Surg; 2010 Aug; 58(5):304-6. PubMed ID: 20680910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Current data concerning neoadjuvant chemotherapy].
    Depierre A
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
    [No Abstract]   [Full Text] [Related]  

  • 58. Current surgical therapy for stage IIIA (N2) non-small cell lung cancer.
    Yanagawa J; Rusch VW
    Semin Thorac Cardiovasc Surg; 2011; 23(4):291-6. PubMed ID: 22443648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung.
    Carruthers R; O'Rourke N; Mohammed N; Hicks J; Brisbane I
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):561-2. PubMed ID: 21676603
    [No Abstract]   [Full Text] [Related]  

  • 60. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.